Vyome Therapeutics Inc.

📍 Princeton, United States🗓 Founded 2010👥 19 employees💰 Last funded Jan 2019

Vyome Therapeutics Inc. is an innovation driven drug development company, with a vision to develop novel drugs for immune-inflammation diseases that can be treated through local administrated agents. Vyome's management team members are the leaders in the field, with deep expertise, demonstrated capability and a proven track record of successfully launching over 50 products in dermatology & other life sciences areas, and building visionary companies. Vyome’s development platform is completely risk mitigated. Vyome has a deep pipeline of IP based products targeting multiple indications. The lead molecule (VB 1953), which targets the huge unmet need in the drug resistant acne prescription market, is currently being evaluated in clinical trials in the United States. Vyome has state-of-the-art infrastructure to carry out all its research and lab development work, with full-fledged formulation, analytical, chemistry, biology & molecular biology, clinical and the regulatory divisions. The infrastructure and the team enables Vyome to conceive ideas, develop them and commercialize them at a rapid pace.

Total investors

Early stage

Mid stage

Late stage

2010

Founded